Company: BIAF
Filing Date: 2025-05-27
Form Type: 424B5
Source: 0001641172-25-012410
Chunk: 29

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 424B5
Chunk 29
---
ited financial statements in addition to any required unaudited interim financial statements with correspondingly 
 reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Securities                      
 Act of 1933, as amended (the “Securities Act”), filings;                                                                               |

| ● | reduced                                                   
 disclosure about our executive compensation arrangements; |

| ● | no                                                                                         
 non-binding advisory votes on executive compensation or golden parachute arrangements; and |

| ● | exemption                                                                                                                            
 from compliance with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant 
 to Section 404(b) of the Sarbanes Oxley Act of 2002 (“SOX”).                                                                         |

We may take advantage of these exemptions for up to five years or such earlier time that we are no longer an “emerging growth company.” We will continue to remain an “emerging growth company” until the earliest of the following: (i) the last day of the fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (ii) the last day of the fiscal year in which our total annual gross revenue is equal to or more than $1.235 billion; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC.

| 2 |

We are also a “smaller reporting company” as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and have elected to take advantage of certain of the scaled disclosures available to smaller reporting companies. To the extent that we continue to qualify as a “smaller reporting company” as such term is defined in Rule 12b-2 under the Exchange Act, after we cease to qualify as an emerging growth company, certain of the exemptions available to us as an “emerging growth company” may continue to be available to us as a “smaller reporting company,” including exemption from compliance with the auditor attestation requirements pursuant to SOX and reduced disclosure about our executive compensation arrangements. We will continue to be a “smaller reporting company” until we have $250 million or more in public float (based on our common stock) measured as of the last business day of our most recently completed second fiscal quarter or, in the event we have no public float (based on our common stock) or a public float (based on